3 Reasons Why Growth Investors Shouldn't Overlook Bristol-Myers (BMY)Zacks Investment Research • 12/05/19
Bristol-Myers Has Now Acquired Celgene — So, Should You Buy BMY Stock?Investors Business Daily • 12/04/19
Bristol-Myers Squibb Meets 80-Plus Relative Strength Rating BenchmarkInvestors Business Daily • 11/27/19
Why I'm Holding On to My Bristol-Myers Squibb Shares Now That the Celgene Acquisition Has ClosedThe Motley Fool • 11/24/19